As tumor markers that tend to be more highly expressed in HCC cells while lowly expressed in normal hepatic cells, GPC3 and AFP can aid in the direct targeting of tumor cells by cellular therapy modalities, such as monoclonal antibodies and Car-T (55, 56). The gene discussed is GPC3; the disease is hepatocellular carcinoma.